Home / Biopharma / Multimodal Data

Partner With Caris

Multimodal Data

Data Solutions for Biopharma

Caris Life Sciences is at the forefront of a data-led revolution in personalized cancer care. In partnership with biopharma innovators, Caris is shaping the future of precision oncology by developing groundbreaking solutions that deliver powerful outcomes. By combining advanced molecular science and artificial intelligence with years of experience and a world-class database comprised of both whole exome and whole transcriptome sequencing, Caris generates actionable insights to help accelerate the development of new medicines and diagnostics.

Data Without Context is Incomplete

Caris is the US market leader in tissue genomic profiling with MI Cancer Seek®. We have tested over 1 million patient cases since 2009. We are unsurpassed when it comes to case volume combined with breadth and depth of multimodal data – molecular testing results matched with claims and real-world data:

Molecular data spanning more than 550,000 matched clinico-genomic profiles and across more than 55 tumor types
Real-world claims data through partnerships to enable the ability to see deeper and farther into patient journey than ever before
Hematoxylin and Eosin images, digital pathology
Algorithm and molecular signature Development

DNA (WES) and RNA (WTS) Across 23,000 Genes

Mapping the Tumor Microenvironment

Repository of Formalin Fixed Paraffin Embedded tissue slides

Connecting molecular biology to clinical outcomes

550K+ matched genomic profiles with claims data
Deeply curated EHR through multiple clinical linkages

Identify ideal patient populations

Molecular data

Total Case Volume

1.0+ Million

Whole Exomes

627,000+

Whole Transcriptomes

678,000+

tissue & protein

Total Pathology Slides

18+ Million

H&E and IHC Digitized Slides

5.6+ Million

Total Image Features Captured

245+ Billion

multimodal data

Matched Clinico-Genomic Profiles

560K+

EHR Partners

Tumor Types

ai & innovation

Digital Pathology Algorithms for Biomarkers

26*

Validated Clinical AI Signatures

*Includes in development

Big Data, Bigger Impact

Big Data

Caris has developed one of the world’s largest clinico-genomic databases, comprising more than half a million patient genomic profiles, most with matched clinical outcomes and digital pathology, and covering a broad spectrum of tumor types.

Artificial Intelligence (AI)

Caris has developed advanced machine learning and artificial intelligence tools to help physicians and researchers navigate deep genomic information to create clinically meaningful solutions in ways never before possible.

Comprehensive Molecular Profiling

Caris–comprehensive molecular profiling is designed to reveal molecular blueprints that helps guide more precise and individualized treatment decisions to improve patient outcomes.

Discover
More

Molecular Intelligence for Biopharma

The fundamental understanding of disease at the molecular level is the essence of precision medicine.

Caris Discovery

Unlock truly novel and otherwise inaccessible targets for your pipeline.

Partner with Biopharma